Jun 13, 2019

Faculty presentations from a CME symposium held at the 2019 AACR Annual Meeting.

Long description:

Faculty presentations from a CME symposium held at the 2019 AACR Annual Meeting. Featuring perspectives from Drs Emmanuel S Antonarakis, Kathleen Moore, Michael J Pishvaian and Melinda Telli.

• PARP Inhibition as a Therapeutic Strategy — Ovarian Cancer at the Vanguard — Dr Moore (00:00)
• Current and Emerging Role of PARP Inhibitors in Metastatic Breast Cancer — Dr Telli (8:45)
• Pancreatic Cancer and PARP Inhibition — What We Know and What We Don’t — Dr Pishvaian (20:45)
• DNA Repair Deficiency in Advanced Prostate Cancer and the Potential Role of PARP Inhibition — Dr Antonarakis (30:18)

Select publications